We collaborated with Geisinger to perform the first study using primary data to uncover the economic burden of preeclampsia.
Preeclampsia is a growing issue, but little is known about the cost to our healthcare system.
In a collaboration between Progenity and Geisinger, a large regional healthcare system, >2,100 mother/infant pairs were matched and evenly distributed among three cohorts of normal, hypertensive, and preeclamptic pregnancies. Primary data from their Geisinger electronic medical and billing records was used to estimate differences in their healthcare costs.
This research was presented at SMFM, and was subsequently published in Obstetrics & Gynecology.